Houston to Miami: How U.S. Cities Are Powering a Two‑Way Global Medical Tourism Boom

Image generated with Ai

The United States is increasingly being viewed as both a premium destination for inbound medical tourists and a powerful source of outbound patients who travel abroad for more affordable care, creating a complex two‑way flow that defines the medical tourism landscape in 2026. Inbound travelers are being drawn to U.S. cities for high‑complexity procedures and advanced technologies, while millions of American residents are being encouraged by cost differentials to consider surgery in countries such as Thailand, Mexico and India, where comparable operations can often be obtained at 50 to 80 percent lower prices.

The United States as a global medical tourism hub

Within the global health travel ecosystem, the U.S. medical tourism market is being recognized as a high‑value segment rather than a high‑volume bargain market. The market was valued at about USD 8.19 billion in 2023 and is projected to reach approximately USD 27.90 billion by 2033, indicating sustained growth over the coming decade. Inbound medical tourism accounted for around 60 percent of that market in 2023 and is expected to remain the fastest‑growing component as the demand for complex and highly specialized treatments continues to increase.

Around 1.9 million inbound medical tourists are estimated to enter the United States every year for care. These patients are generally not traveling for minor or low‑cost procedures. Instead, they tend to arrive for major cardiac surgery, advanced orthopedic interventions, neurosurgery and oncology, as well as for highly technical imaging and sophisticated diagnostic workups. Many of them arrive after exhausting options in their home countries or after being referred by local physicians who recognize that certain therapies or technologies remain concentrated in leading U.S. centers.

In market analyses, several states are repeatedly highlighted as major hubs within this inbound picture. Florida, California and New York are frequently mentioned, alongside other states that host globally ranked hospitals and research centers. International patients consistently report that they are drawn by access to cutting‑edge technology, highly specialized treatment teams and world‑renowned experts whose second opinions can carry considerable weight in complex decision making. The willingness of patients to travel long distances and pay premium prices underlines the degree of trust placed in U.S. health systems at the top tier of medical tourism.

Leading U.S. city‑level hubs and their roles

Houston: a powerhouse for oncology and complex care

Houston has emerged as one of the most important cities in the world for medical tourism focused on complex care. The city is anchored by the Texas Medical Center, which is described as the world’s largest medical complex. This cluster encompasses 21 hospitals as well as numerous research and academic institutions and has been receiving thousands of international patients annually over several decades. The density of facilities and the integration of clinical care with research and education have made the area a magnet for patients with challenging diagnoses.

Within this ecosystem, MD Anderson Cancer Center is widely recognized as a global leader in oncology. International patients travel to Houston for the treatment of sarcoma, leukemia, breast and lung cancers, among many other conditions. They also seek second opinions and access to cutting‑edge clinical trials that may offer novel therapeutic options unavailable elsewhere. Future Market Insights has noted that the Texas Medical Center draws significant numbers of patients from Latin America who travel for advanced orthopedic and cardiovascular procedures, aided by direct flights into Houston and the availability of bilingual medical staff.

A key factor in Houston’s appeal for medical tourism lies in the support structures that have been built around international patients. Institutions such as MD Anderson operate dedicated International Patient Centers staffed by multilingual teams who coordinate admissions, arrange clinical schedules, assist with lodging, help with visa documentation and address cultural and dietary needs. This highly structured pathway reduces friction for patients and caregivers navigating unfamiliar systems. As a result, Houston can be credibly presented as the flagship U.S. city for complex oncology and high‑acuity specialty care in the medical tourism narrative, especially for patients coming from Latin America, the Middle East and selected parts of Asia.

Rochester, Cleveland, Boston and New York: elite academic hubs

Beyond Houston, several other U.S. cities anchor their own powerful medical tourism niches through academic medicine. Analyses of the inbound market list institutions such as The Johns Hopkins Hospital in Baltimore, Mayo Clinic in Rochester, Jacksonville and Phoenix, Cleveland Clinic in Cleveland, Massachusetts General Hospital in Boston and New York‑Presbyterian Hospital in New York as key participants in international patient care. These hospitals are widely known for their research output, subspecialty depth and high rankings in global hospital evaluations.

Mayo Clinic, for example, is cited as receiving thousands of international patients every year, particularly those with cancer and neurological conditions. Many of these patients arrive with complex histories and lengthy diagnostic journeys; at Mayo, multidisciplinary teams are assembled to evaluate cases, coordinate testing and develop integrated treatment plans that draw on expertise across departments. This strong emphasis on complex case management has become a hallmark of the Mayo model, making Rochester and its sister campuses important nodes in the medical tourism map.

Cleveland Clinic is similarly prominent in the global reputation hierarchy. It is consistently ranked among the top hospitals worldwide and is widely recognized for its heart program, oncology services, neurologic care and advanced surgery. An international patient service is maintained to provide personalized care plans, bilingual coordinators and logistical support for overseas visitors. Boston, anchored by Massachusetts General Hospital and its network of Harvard‑affiliated institutions, and New York, with centers such as New York‑Presbyterian, share comparable positioning for neurology, oncology, transplant and research‑linked treatments. These hubs are less focused on tourism packages and more on referral‑driven, ultra‑specialized flows in which patients and their families make deliberate decisions to cross borders in search of best‑in‑class expertise.

Miami and Florida: cosmetic, bariatric and Latin American‑focused care

Florida occupies a distinct place within U.S. medical tourism as a bridge between North America, Latin America and the Caribbean. Market‑level statistics identify the state as one of the major hubs for inbound patients, particularly those coming from Spanish‑speaking countries and nearby island nations. By the end of 2025, clinics in Florida were reported to have expanded medical tourism packages targeted specifically at Latin American patients who seek cosmetic surgery and bariatric procedures. These packages are marketed on the basis of shorter wait times and more competitive pricing than the broader U.S. average, paired with resort‑style environments that blend treatment with leisure.

Within Florida, Miami stands out as a leading city for plastic surgery tourism. Future Market Insights highlights Miami as a destination where patients from Europe and Latin America travel for high‑quality liposuction, rhinoplasty and breast augmentation. These services are frequently sold as bundled packages that combine surgical care with hotel stays and structured post‑operative recovery arrangements. From a medical tourism perspective, Florida and especially Miami can therefore be framed as the U.S. entry point for sun‑plus‑surgery experiences, particularly in the aesthetic and weight‑loss segments.

Los Angeles and California: aesthetics, wellness and technology

California is also cited as a major U.S. hub for medical tourism, with strong roles in plastic surgery, wellness and integrative care. Los Angeles is specifically mentioned alongside Miami as a leading city for aesthetic medical tourism, attracting patients from around the world for cosmetic surgery packages. These packages often include accommodation, nursing support and curated recovery experiences in surroundings that benefit from mild weather and established hospitality infrastructure.

In October 2025, wellness retreats in California were reported as having integrated AI‑driven diagnostics into their offerings, blending advanced health assessments with spa treatments and holistic wellness programs. High‑net‑worth individuals from Europe have been targeted for preventive health check‑ups and lifestyle medicine, illustrating how medical tourism is evolving beyond illness‑focused travel to include proactive and personalized health management. This integration makes California, and Los Angeles in particular, a compelling case study in the convergence of medical tourism, wellness, digital diagnostics and luxury hospitality.

New York and Boston: high‑end specialty referrals

New York appears regularly alongside Florida and California as a major medical tourism hub. Institutions such as New York‑Presbyterian Hospital and other top academic centers in the city attract international patients for complex cardiology, transplant and oncology care. Many of these patients are referred for second opinions or for procedures where U.S. centers are perceived as offering superior experience or access to innovative therapies.

Boston, anchored by Massachusetts General Hospital and the broader Harvard‑affiliated system, is also recognized as a key destination for international patients seeking advanced neurology, oncology and research‑linked treatments. Access to experimental therapies and participation in clinical trials are frequently highlighted advantages for those willing to travel. In the medical tourism context, New York and Boston are best described as high‑prestige destinations where patients seek advanced surgery and cutting‑edge interventions that may not be accessible at home.

Inbound numbers in context

Taken together, U.S. inbound medical tourism is estimated at roughly 1.9 million patients per year, according to aggregated data published by Market.us and drawing on sources such as Patients Beyond Borders and the Medical Tourism Association. In 2023, inbound medical tourism captured about 60.09 percent of U.S. medical tourism revenue and is projected to grow faster than domestic or outbound segments over the next decade, primarily because of rising demand for high‑complexity treatments such as oncology, organ transplantation, neurosurgery and robotic surgery that remain concentrated in leading U.S. centers.

At the same time, these inbound figures exist alongside larger outbound flows, as U.S. residents seek lower‑cost care in Latin America and Asia for elective or semi‑elective surgeries. This dual dynamic reinforces the idea that the United States occupies two contrasting roles within medical tourism: as a premium destination for patients who prioritize quality and as a high‑cost origin country whose residents often look abroad for affordability.

Cost comparison: U.S. versus Thailand for major surgeries

The decision of many American patients to travel abroad is driven largely by price differences. Self‑pay cost comparisons compiled across global hospitals reveal dramatic gaps between typical U.S. charges and those in Thailand for major surgical procedures. For coronary artery bypass grafting, or heart bypass surgery, the cost in the United States often begins around USD 123,000 for self‑pay patients and can range between USD 70,000 and 150,000 or more, depending on hospital and case complexity. In Thailand, the same category of procedure is typically priced at around USD 15,000 to 25,000 in major cardiac centers, representing savings of roughly 70 to 85 percent.

A similar pattern is observed in heart valve replacement. In the U.S., self‑pay costs are placed at around USD 170,000 on average, whereas in Thailand these operations are often offered for USD 11,000 to 28,000. Hip replacement in the United States is commonly quoted at USD 40,000 or more for self‑funded patients, while in Thailand it is frequently available for USD 12,000 to 15,000, often including hospital stay and implants. For knee replacement, U.S. prices are often around USD 35,000 or higher, with one UK‑based comparator quoting approximately GBP 24,871, roughly in the same range. In Thailand, knee replacement is frequently priced at around USD 10,000 to 14,000, or around GBP 9,000, which implies cost reductions in the 50 to 70 percent range.

These comparisons align with broader estimates showing that major heart surgeries in the United States often cost USD 70,000 to over 150,000, contrasted with roughly USD 10,000 to 25,000 in leading emerging‑market destinations. For medical tourists from the U.S., such differentials can translate into tens of thousands of dollars in savings, even after including flights and hotel stays, and they explain why cardiac, orthopedic and bariatric procedures form a substantial share of outbound medical tourism.

Risks and safety concerns in medical tourism

Against this backdrop of substantial cost savings, U.S. health authorities emphasize the importance of understanding the risks associated with traveling abroad for medical care. The U.S. Centers for Disease Control and Prevention and infection‑prevention experts highlight three broad risk domains: infections, variable facility standards and continuity of care.

In terms of infection risk, the CDC reports that the most common complications among medical tourists tend to be infection‑related. These include surgical site infections, bloodstream infections and transmissible diseases such as hepatitis B and C and HIV, as well as donor‑derived infections following organ or tissue transplantation. Attention is also being drawn to antimicrobial‑resistant organisms such as carbapenem‑resistant Enterobacterales and Candida auris, which are of particular concern in some low‑cost surgery hubs where antibiotic use and infection control may not match U.S. standards.

Regarding standards and accreditation, infection‑control specialists note wide variation in regulatory frameworks, hygiene practices and quality oversight between countries and even between facilities within the same country. Some hospitals meet or exceed international best practices, while others operate with weaker accountability. International accreditation programs, including Joint Commission International and specialist certifications such as QUAD A’s International Medical Tourism Certification, are highlighted as tools to identify facilities that are more likely to maintain robust safety, sterilization and quality systems. However, accreditation is not regarded as an absolute safeguard against all risks.

Continuity of care represents another significant challenge. Bariatric surgery, major orthopedic interventions and complex cardiothoracic operations all require careful pre‑operative evaluation and long‑term follow‑up to manage complications, adjust medications and support lifestyle changes. Medical specialty societies in the United States have warned that when such procedures are performed overseas, follow‑up can become fragmented. Some local physicians may be hesitant to manage complications arising from surgery performed abroad, and full operative records or implant data may not always be readily available to the care teams at home. Telemedicine can help bridge some of these gaps through remote consultations, but complications arising after return to the U.S. may still be more difficult to manage without complete and timely documentation.

From a medical tourism perspective, these risk factors underscore the need for careful destination and hospital selection, rigorous pre‑travel planning and clear arrangements for follow‑up care upon return.

Top outbound destinations for American medical tourists

Studies of the North America outbound medical tourism market consistently identify a set of preferred countries among U.S. travelers. Thailand is frequently described as the Medical Tourism Capital of Asia, attracting millions of patients annually through a combination of JCI‑accredited hospitals, competitive prices and resort‑style recovery environments. India is well known for its expertise in cardiology, oncology and orthopedic surgery, supported by large private hospital chains that cater to international patients at prices far below U.S. levels.

Mexico is often ranked as the top choice for U.S. and Canadian patients, largely because of geographic proximity and savings that can reach around 70 percent for some procedures. Dental treatments, bariatric surgery and cosmetic surgery feature prominently in U.S.–Mexico medical travel, supported by cross‑border logistics and English‑speaking staff in many clinics. Turkey is a leading destination for hair transplants, orthopedics and cosmetic surgery, often combining procedures with cultural tourism experiences in Istanbul and other cities. Costa Rica is widely recognized for dental work, orthopedics and cosmetic surgery and is frequently praised for high patient satisfaction and natural landscapes that support recovery.

Colombia has built a reputation for cosmetic surgery and selected orthopedic and cardiac procedures at competitive prices. Singapore functions as a premium hub for oncology, cardiovascular care, organ transplants and advanced diagnostics, positioned at a higher price point but with strong quality metrics. The United Arab Emirates, especially Dubai and Abu Dhabi, has invested heavily in positioning itself as a luxury medical destination for cosmetic surgery, fertility treatment, orthopedics and dentistry within high‑end hospitality settings. Malaysia offers affordable cardiac, orthopedic and general surgery in modern private hospitals, often promoted as part of family‑friendly tourism packages. Brazil continues to enjoy a long‑standing reputation for cosmetic and reconstructive surgery and draws many patients for aesthetic and corrective procedures.

These destinations align with broader global assessments that identify Asia‑Pacific, Latin America and the Middle East as the primary regions selected by North American outbound patients.

Most popular procedures among American medical tourists

Across global and U.S.‑focused analyses, a consistent pattern can be observed in the services that American medical tourists seek. Cosmetic and plastic surgery occupies a major share, accounting for roughly 25 percent of global medical tourism volume. Procedures such as breast augmentation, liposuction, facelifts, rhinoplasty and hair transplantation are widely requested, with Mexico, Turkey, Brazil and Thailand frequently referenced as key providers in this segment.

Dental treatments form another major pillar of the market, with dental tourism estimated at around 15 percent of global medical tourism activity. This includes implants, crowns, veneers and complex restorative work. Healthgrades has noted that dental implants are the single most popular medical tourism procedure for residents of the United States, Western Europe and Australia, largely because dental insurance in many of these countries does not fully cover implant treatments. Mexico, Costa Rica and Colombia are prominent destinations for U.S. dental tourists, thanks to proximity and highly competitive pricing.

Bariatric surgery, including gastric sleeve and gastric bypass procedures, is widely promoted at discounts of 40 to 80 percent compared with U.S. prices. Mexico has become particularly popular for American bariatric patients due to its geographic proximity, the presence of large English‑speaking teams and established cross‑border pathways. Orthopedic procedures, especially hip and knee replacements, are central to medical tourism flows, as typical U.S. prices of USD 35,000 to 50,000 contrast with approximately USD 10,000 to 15,000 in Thailand or USD 12,000 to 16,000 in Costa Rica.

Cardiac surgery represents another key category with large absolute savings. Heart bypass and heart valve replacement operations are often priced in the United States at USD 80,000 to 120,000 or more, whereas India can offer bypass procedures at around USD 7,000 and Thailand at around USD 15,000 to 25,000. Fertility treatments and in vitro fertilization, including egg donation and other assisted reproductive technologies, also encourage outbound travel to countries such as India, Mexico and parts of Eastern Europe where costs are lower and regulatory frameworks may permit more treatment options. Ophthalmology completes the core cluster, with Lasik and cataract surgery commonly performed in medical tourism contexts; U.S. consumers can often save 50 percent or more on these elective eye procedures when they travel abroad.

Taken together, these trends show a medical tourism landscape in which the United States serves as a premium destination for complex, high‑risk and technologically advanced treatments while simultaneously acting as a major origin country for cost‑sensitive surgeries and elective procedures. Patients and providers are increasingly navigating this global marketplace with attention to cost, quality, safety and long‑term outcomes, making medical tourism a central feature of international health care rather than a peripheral niche.